Address
Email address
Phone number
Website
https://www.roche.eeRoche EestiRoche töötab välja innovaatilisi ravimeid ja diagnostikavahendeid, mis aitavad miljoneid patsiente terves maailmas
Name
Roche Eesti Osaühing
Registry code
11124024
VAT number
EE100987243
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
15.04.2005 (19)
Financial year
01.01-31.12
Capital
127 823.00 €
Activity
74901 - Other professional, scientific and technical activities n.e.c. 46761 - Wholesale of other intermediate products
-
-
-
-
-
-
-
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Kadri Mägi-Lehtsi
| - | Procurator | - | |
| Kea Kapsta
| - | Procurator | - | |
| Kätlin Luik
| - | Procurator | - | |
| Mart Vain
| - | Procurator | - | |
| Martin-Kaspar Sild
| - | Procurator | - | |
| Stan Nahkor
| - | Procurator | - | |
| Ehab Youssef
| - | Board member | - |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q4 | 10 924 642.15 € | 511 202.61 € | 276 622.19 € | 41 |
| 2024 Q3 | 19 994 735 € | 1 013 925.43 € | 321 168.31 € | 42 |
| 2024 Q2 | 15 446 917.56 € | 1 020 572.68 € | 544 279.91 € | 40 |
| 2024 Q1 | 14 368 515.57 € | 710 768.4 € | 262 913.81 € | 40 |
| 2023 Q4 | 14 820 558.81 € | 622 566.09 € | 222 730.57 € | 42 |
| 2023 Q3 | 11 967 874.45 € | 596 318.86 € | 298 659.87 € | 39 |
| 2023 Q2 | 13 600 088.74 € | 917 477.05 € | 546 488.63 € | 41 |
| 2023 Q1 | 16 733 279.75 € | 664 163.36 € | 243 972.61 € | 46 |
| 2022 Q4 | 14 216 392.17 € | 511 528.85 € | 246 442.96 € | 49 |
| 2022 Q3 | 11 618 013.45 € | 573 874.97 € | 266 824.68 € | 57 |
| 2022 Q2 | 16 503 047.61 € | 884 005.91 € | 484 157.93 € | 57 |
| 2022 Q1 | 11 692 082.3 € | 594 342.44 € | 227 274.04 € | 57 |
| 2021 Q4 | 9 318 199.34 € | 489 346.08 € | 212 227.34 € | 59 |
| 2021 Q3 | 13 027 920.39 € | 463 371.51 € | 252 542.59 € | 60 |
| 2021 Q2 | 10 739 551 € | 758 353.36 € | 375 587.05 € | 60 |
| 2021 Q1 | 10 229 222.37 € | 520 910.96 € | 199 058.51 € | 60 |
| 2020 Q4 | 12 449 889.14 € | 483 769.32 € | 195 035.48 € | 66 |
| 2020 Q3 | 8 285 768.56 € | 630 823.71 € | 242 931.07 € | 66 |
| 2020 Q2 | 11 301 347.67 € | 779 322.77 € | 452 861.62 € | 64 |
| 2020 Q1 | 9 436 989.16 € | 490 764.27 € | 188 776.23 € | 58 |
